RxDoctor Payments Data

Gregory Stockbridge, OD

Optometrist · Smithfield, NCNPI 1336182427

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,446 of the $4,160 with a category attached, or 82.8%. 11 manufacturers reported payments, led by Coopervision Inc. at 33.0% of the total.

$4,160in general payments, 2019–2025

Across 69 payments — averaging $60.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$1K
  • ABB Con-cise Optical Group LLC$1K
  • Johnson & Johnson Vision Care, Inc.$903
  • Alcon$299
  • Optos, Inc.$176
  • Maculogix, Inc.$174
  • plus $158 from 5 others
$240in research payments, 2019–2025

Across 6 payments — averaging $40.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Notal Vision, Inc.$240

What the payments were for

  • Consulting fees$2877%
  • Food & beverage$3,44683%
  • Gifts$291%
  • Entertainment$39910%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,160 in reported general payments places this provider in the 85th percentile of 1,326 optometrist providers in North Carolina.

See all optometrist providers in North Carolina →

Medicare billing

Part B allowed, 2024
$77,314
Medicare patients
329
Services billed
1,100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine47$34,633
LumiganBimatoprost22$6,657
Tobramycin-DexamethasoneTobramycin/Dexamethasone64$2,693
Brimonidine Tartrate62$2,624
Latanoprost256$2,371
CombiganBrimonidine Tartrate/Timolol11$2,114
Prednisolone Acetate33$986
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat44$733
Dorzolamide Hcl35$589
Timolol Maleate53$460
Doxycycline Monohydrate21$202

Paid to pharmacies, not to this prescriber.

Other optometrist in Smithfield

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →